Gene Query: FANCL

Dataset Description Geneva Score
Identification of transcription start sites for human A549 cell line using ReCappable-seq 18.06
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 15.89
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 14.55
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 12.02
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 11.7
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 11.45
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 11.45
Short and Long RNA sequencing of human mature erythrocytes 10.88
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 10.74
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 10.74
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 10.38
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 10.05
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 9.62
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 9.04
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 8.78
Gene expression in PANC1 cells treated with Rakicidin 8.61
RNA sequencing of primary human platelets and in vitro cell lines 8.56
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 8.46
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 8.0
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 7.74
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 7.7
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.5
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 7.25
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 7.06
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 7.02
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 7.02
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 6.86
Oncogenic MYC induces a dependency on the spliceosome in human cancer 6.8
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 6.8
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.77
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 6.75
RNAseq Analysis in glioblastoma cells treated with Mepazine 6.74
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 6.59
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 6.46
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 6.42
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 6.32
Transcriptome-wide identification of CELF2 functional targets in T cells 6.25
MYCL and EP400 are required for Max and MCPyV mediated gene activation 6.05
RNAseq Study in CC-671 Treated Cal-51 Cells 5.82
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 5.68
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 5.63
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.63
Regulation of protein translation during mitosis 5.61
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 5.59
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 5.47
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 5.37
Transciptomic profiling of human fetal lung samples 5.31
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 5.28
Transcriptome analysis of U87 cells upon LINC00152 knockdown 5.26
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 5.23
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.23
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.21
Transcriptome analysis of Zika infected neural stem cells 5.17
Zika infected neural stem cells 5.17
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 5.16
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.14
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.08
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 5.08
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.02
DART-seq: an antibody-free method for global m6A detection 4.95
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.93
Genome-wide discovery of human splicing branchpoints 4.88
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 4.85
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 4.84
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 4.83
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.79
Biological effect of chronic mistranslation in mammalian cells 4.7
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 4.68
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 4.61
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 4.53
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 4.53
Effect of Influenza virus infection on lncRNA expression in A549 cells 4.5
Single-Cell Genotyping of Transcriptomes 4.48
RNA-seq of Single-Cell Genotyping of Transcriptomes 4.48
Hypoxic transcriptome of SQ20B human head and neck cancer cells 4.46
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.4
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.4
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 4.36
Primate transcript and protein expression levels evolve under compensatory selection pressures 4.35
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 4.32
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.3
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 4.3
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 4.28
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 4.24
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 4.22
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 4.16
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 4.16
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.15
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 4.13
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 4.13
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 4.11
LncRNA expression profiling of ischemic stroke patients 4.11
scRNASeq analysis of cycling cardiomyocytes 4.09
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 4.08
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.07
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 4.07
RNA-seq of tumor cells following angiopellosis extravasation 4.04
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 4.03
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 4.02
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.02
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.01
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 3.98
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.97
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 3.91
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.9
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.89
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 3.88
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.86
Single-cell analysis of adult human ovary using 10X genomics 3.85
Expression by CD133+ cells isolated from the adult human exocrine pancreas 3.78
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 3.69
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.67
KLF6-dependent transcription in renal cancer cells 3.66
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 3.63
The comparison of high-throughput single-cell RNA-seq methods 3.61
Illumina Total RNA-seq in HeLa 3.61
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 3.58
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 3.58
Gene expression in GBM with Cav3.2 inhibition 3.57
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 3.57
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 3.56
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.54
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 3.54
p53 activity results in DNA replication fork processivity 3.53
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 3.53
Transcriptional landscape changes during human embryonic stem cell derivation 3.51
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.5
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 3.5
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 3.48
Endometrial transcriptome and PGR cistrome in cycling fertile women 3.48
Tracking of dCas9-methyltransferase footprints 3.44
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.43
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 3.41
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 3.4
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 3.4
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 3.38
The pause-initiation limit restricts transcription activation in human cells 3.38
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.36
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 3.36
Dynamic 3D chromosomal landscapes in acute leukemia 3.36
RNAseq of HEK293 cells after Chtop knockdown 3.35
Co-transcriptional loading of RNA export factors shapes the human transcriptome 3.35
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 3.35
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.33
Identification of a LIF-responsive replication-competent human β cell 3.3
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 3.29
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 3.29
Discovering human diabetes-risk gene function with genetics and physiological assays 3.27
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.21
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 3.17
Analysis of transcriptional regulation by Myt1 and Myt1l 3.15
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 3.15
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 3.12
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 3.12
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 3.12
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.1
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 3.09
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 3.09
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 3.06
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.05
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.04
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.04
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 3.03
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 3.03
An optimization system for isolating and sequencing of single human colon cancer cells 3.03
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 3.02
Hepatitis C virus functionally sequesters miR-122 3.01
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 3.01
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 3.0
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 2.99
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 2.96
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 2.96
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 2.95
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 2.93
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 2.93
SRSF1 role in cellular gene expression and splicing 2.92
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 2.9
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 2.88
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 2.86
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.86
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 2.86
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 2.85
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 2.85
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.83
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.83
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 2.83
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.82
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 2.82
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 2.81
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 2.8
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 2.8
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 2.8
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 2.79
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 2.79
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 2.77
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 2.77
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 2.77
High-efficiency RNA-based reprogramming of human primary fibroblasts 2.77
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 2.75
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 2.75
A transcriptome-wide divergence in protein translation scales with LIN28B expression 2.71
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 2.71
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 2.69
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.67
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 2.66
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 2.66
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 2.66
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 2.64
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.63
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 2.62
An integrative analysis of non-coding regulatory DNA variations associated with autism 2.62
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 2.6
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 2.6
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.58
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.58
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 2.56
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 2.56
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 2.55
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 2.55
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 2.55
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 2.54
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 2.54
Landscape of H3K4me3 in human CD19 cells 2.53
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 2.52
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.51
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.51
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.49
Gene expression analysis upon mtDNA depletion 2.49
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.48
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 2.47
RNAseq of T-ALL upon long non coding rna purturbation 2.46
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.44
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 2.43
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 2.43
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 2.41
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 2.4
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.37
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.35
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 2.35
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 2.35
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.33
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 2.32
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 2.32
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 2.31
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 2.29
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.28
RNA sequencing analysis of selumetinib-resistant CRC cells lines 2.28
SLAM-seq for K562 endogenous mRNA decay 2.27
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.26
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 2.25
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.22
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.22
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 2.19
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 2.19
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 2.19
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 2.19
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 2.19
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 2.18
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  2.18
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 2.18
EWSR1 influences alternative splicing through direct and indirect mechanisms 2.15
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 2.13
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 2.12
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 2.11
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 2.11
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 2.11
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 2.11
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.09
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.09
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 2.09
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.08
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.06
RNA-seq of cancer cell lines treated with T-025 2.06
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.05
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 2.05
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.04
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.03
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.03
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.02
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 2.01
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 2.01
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.01
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 2.0
Transcriptome analysis of CNS leukemia 2.0
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 1.99
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.99
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 1.96
Gene induction by the USP6 oncogene in response to interferon 1.95
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 1.92
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.9
The contribution of Alu exons to the human proteome 1.89
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 1.89
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.89
Global analysis of enhancer targets: Mosaic-seq 1.86
FGF2 regulation of gene expression in stable inducible Neurons 1.84
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.84
Novel Targeting of Transcription and Metabolism in Glioblastoma 1.84
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 1.83
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 1.82
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development [BM low-input mRNA-seq] 1.81
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 1.81
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 1.81
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.78
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.78
circRNA profile in hypopharyngeal cancer 1.78
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.78
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 1.78
SF3B1 Degron knockdown RNA-seq 1.76
The transcriptome and chromatin accessbility landscape of mammalian germline 1.74
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.71
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 1.7
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.7
RNA-Seq of PRMT1 overexpression ECA109 cells 1.69
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.68
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.66
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.66
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.65
Iron response of HepG2 cells 1.65
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.65
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 1.64
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 1.64
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 1.64
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 1.63
Silencing p300 in MCF7 cells to study expression and alternative splicing 1.63
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.62
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 1.62
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.61
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 1.59
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 1.58
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.52
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.52
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 1.49
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 1.49
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.48
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 1.47
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 1.47
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 1.46
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.45
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.43
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.43
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.43
Next Generation Sequencing of human SMA and healthy control Motor Neurons 1.42
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 1.4
Exploring ILF2 regulatory genes by next-generation sequencing 1.4
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.4
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 1.4
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.38
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.36
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.34
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.34
High-resolution comparative analysis of great ape genomes 1.34
RNA-seq of SCLC PDX models treated with EP 1.31
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 1.3
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.28
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 1.27
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 1.23
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.22
Global transcriptome analysis of HAP1 cells 1.22
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 1.21
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 1.2
Epigenomic conservation of transposable element silencing 1.19
Epigenomic conservation of transposable element silencing [RNA-seq] 1.19
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.19
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 1.19
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 1.16
KSDM1b Role in Ewing Sarcoma 1.15
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.13
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.13
O-glcnAc reprograms cellular energetics 1.13
Analyses of T-ALL (COG study) 1.1
RNA sequencing of T-ALL (COG study) 1.1
Gene expression changes due to PARP knockdown in human cells 1.1
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 1.08
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.05
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.05
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.04
Recovery and analysis of nascent RNA 1.04
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 1.03
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.0
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.0
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.99
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.99
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 0.99
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 0.99
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 0.98
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 0.95
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 0.92
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 0.92
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.9
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.9
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.87
Measure transcript integrity using RNA-seq data 0.85
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.85
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.83
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.83
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.82
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.82
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.81
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.81
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 0.77
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.77
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.76
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.76
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.75
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.74
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 0.74
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 0.74
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.72
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.72
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.72
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.72
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 0.7
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 0.7
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 0.7
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.69
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.67
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.66
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.66
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.66
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.66
N6-methyladenine DNA Modification in Glioblastoma 0.65
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 0.62
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.61
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.57
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.55
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 0.55
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 0.55
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.54
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.53
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.53
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.53
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.52
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.51
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.5
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 0.5
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.48
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.48
JAK dependent survival of ALK- ALCL 0.48
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.48
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.47
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.47
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.45
Transcriptome of EBV-infected gastric cancer cell lines 0.45
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.45
The DNA methylation landscape of human melanoma [RNA-Seq] 0.45
The DNA methylation landscape of human melanoma 0.45
Total RNA-seq in ALL-SIL upon TLX1 knockdown 0.45
Human T-cell lymphoblastic lymphoma samples and control thymuses 0.42
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 0.42
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 0.42
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.41
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.4
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.38
Role of FGFR1 in neuronal devlopment 0.37
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.36
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.36
hNSCs siRNA NOVA2 0.35
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.34
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.33
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.31
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.29
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.29
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 0.28
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.25
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.24
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.24
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.23
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.23
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.22
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.22
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.21
Gene expression signatures of innate lymphoid cells from human blood 0.21
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.2
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.19
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.18
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.17
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.17
CD73 knockdown effect in pancreatic cancer cell lines 0.15
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 0.14
RNA-seq of CD33 KO and control HSPCs 0.11
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 0.1
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.1
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.1
RNA-seq in endometrial stromal tumors 0.1
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.09
Regulation of hypoxia-inducible factor activity by ZMYND8 0.08
Human Treg NaCl stimulation 0.08
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 0.07
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.07
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.07
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 0.07
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.06
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.05
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.05
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.04
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.03
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.03
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.03
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.01
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation